No long available in the United States Discontinued November 2020Shingles Prophylaxis Zostavax was approved by the FDA in 2006, but is no longer available in the United States as of November 2020 The recombinant zoster vaccine (Shingrix) is available Mechanism of Action Conveys active immunity by stimulating production of endogenously produced antibodies No images available for this drug. No images available for this drug.A Patient Handout is not currently available for this monograph.Print